HS
IRON icon

HighVista Strategies’s Disc Medicine IRON Stock Holding History

HighVista Strategies’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+14,219
New +$977K 0.24% 112
2025
Q3 		– Sell
-6,733
Closed -$357K – 163
2025
Q2 		$357K Buy
6,733
+275
+4% +$12.9K 0.13% 136
2025
Q1 		$321K Hold
6,458
– – 0.12% 137
2024
Q4 		$409K Sell
6,458
-3,107
-32% -$180K 0.15% 127
2024
Q3 		$470K Buy
+9,565
New +$449K 0.16% 132

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HighVista Strategies's IRON Position: Q2 2026 in Review

HighVista Strategies opened a new position in Disc Medicine (IRON) in Q2 2026: 14,219 shares worth $1.04M. The stake represents 0.24% of the portfolio and ranks #112 among its holdings. This is a return to the name: HighVista Strategies previously reported a position in IRON as recently as Q2 2025.

HighVista Strategies first reported a position in IRON in Q3 2024 and has held it in 5 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • HighVista Strategies held 14,219 shares of Disc Medicine worth $1.04M as of Q2 2026.
  • Disc Medicine was a new HighVista Strategies position in Q2 2026.
  • Disc Medicine made up 0.24% of HighVista Strategies's portfolio in Q2 2026, its #112 holding.
  • HighVista Strategies first reported a position in Disc Medicine in Q3 2024 and has held it in 5 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.